Creo Medical Group (STU:1RC) EBITDA Margin % : -61.59% (As of Dec. 2023)

Creo Medical Group EBITDA Margin % Chart

Creo Medical Group Annual Data
	Trend	Feb14	Feb15	Feb16	Jun17	Dec19	Dec20	Dec21	Dec22	Dec23
EBITDA Margin %		Get a 7-Day Free Trial				-141,153.33	-230.05	-108.95	-101.10	-67.21

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial												-143.40	-106.62	-95.59	-72.61	-61.59

Competitive Comparison of Creo Medical Group's EBITDA Margin %

For the Medical Devices subindustry, Creo Medical Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's EBITDA Margin % falls into.

Creo Medical Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Creo Medical Group's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Creo Medical Group's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group  (STU:1RC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Creo Medical Group EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (STU:1RC) Business Description